Does the PI3K pathway promote or antagonize regulatory T cell development and function?

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Soond, Dalya R ^a   Slack, Elizabeth C M ^a,b   Garden, Oliver A ^b   Patton, Daniel T ^c   Okkenhaug, Klaus ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Akt; Autoimmunity; Foxo; Inflammation; Mtor; Pi3k; T cell; Treg

Indexed keywords

EID: 84874205927     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00244     Document Type: Article

References (99)

1. Barber, D. F., Bartolome, A., Hernandez, C., Flores, J. M., Fernandez-Arias, C., Rodriguez-Borlado, L., Hirsch, E., Wymann, M., Balomenos, D., and Carrera, A. C. (2006). Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion. J. Immunol. 176, 589-593.
2. Basu, S., Golovina, T., Mikheeva, T., June, C. H., and Riley, J. L. (2008). Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J. Immunol. 180,5794-5798.
3. Battaglia, M., Stabilini, A., and Roncarolo, M. G. (2005). Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105, 4743-4748.
4. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, E T., Chance, P. F., and Ochs, H. D. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21.
5. Boissonnas, A., Scholer-Dahirel, A., Simon-Blancal, V., Pace, L., Valet, F., Kissenpfennig, A., Sparwasser, T., Malissen, B., Fetler, L., and Amigorena, S. (2010). Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 32, 266-278.
6. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Serfling, E., Heib, V., Becker, M., Kubach, J., Schmitt, S., Stoll, S., Schild, H., Staege, M. S., Stassen, M., Jonuleit, H., and Schmitt, E. (2007). Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303-1310.
7. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E., Galas, D., Ziegler, S. F., and Ramsdell, E (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lympho-proliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73.
8. Bruno, L., and Merkenschlager, M. (2008). Directing T cell differentiation and function with small molecule inhibitors. Cell Cycle 7, 2296-2298.
9. Buckler, J. L., Walsh, P. T., Porrett, P. M., Choi, Y., and Turka, L. A. (2006). Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J. Immunol. 177, 4262-4266.
10. Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., and Ley, T. J. (2007). Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646.
11. Chen, J., Chen, Y. G., Reifsnyder, P. C., Schott, W H., Lee, C. H., Osborne, M., Scheuplein, F., Haag, E, Koch-Nolte, F., Serreze, D. V., and Leiter, E. H. (2006). Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmu-nity in an ADP-ribosyltransferase 2-dependent fashion. J. Immunol. 176,4590-4599.
12. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., Mcgrady, G., and Wahl, S. M. (2003). Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886.
13. Chen, W., Liang, X., Peterson, A. J., Munn, D. H., and Blazar, B. R. (2008). The indoleamine 2, 3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 181, 5396-5404.
14. Chung, D. J., Rossi, M., Romano, E., Ghith, J., Yuan, J., Munn, D. H., and Young, J. W (2009). Indoleamine 2, 3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114, 555-563.
15. Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J., Mellor, A. L., Ron, D., and Waldmann, H. (2009). Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. U.S.A. 106, 12055-12060.
16. Collazo, M. M., Wood, D., Paraiso, K. H., Lund, E., Engelman, R. W., Le, C. T., Stauch, D., Kotsch, K., and Kerr, W G. (2009). SHIP limits immunoregulatory capacity in the T-cell compartment. Blood 113, 2934-2944.
17. Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., and Vignali, D. A. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569.
18. Crellin, N. K., Garcia, R. V., and Levings, M. K. (2007). Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109,2014-2022.
19. Cretney, E., Xin, A., Shi, W., Minnich, M., Masson, F., Miasari, M., Belz, G. T., Smyth, G. K., Busslinger, M., Nutt, S. L., and Kallies, A. (2011). The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12, 304-311.
20. Daniel, C., Wennhold, K., Kim, H. J., and Von Boehmer, H. (2010). Enhancement of antigen-specific Treg vaccination in vivo. Proc. Natl. Acad. Sci. U.S.A. 107, 16246-16251.
21. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo, V K., Strom, T. B., and Robson, S. C. (2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265.
22. Delgoffe, G. M., Kolw, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., and Powell, J. D. (2009). The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832-844.
23. Durand, C. A., Hartvigsen, K., Fogelstrand, L., Kim, S., Iritani, S., Vanhaesebroeck, B., Witztum, J. L., Puri, K. D., and Gold, M. R. (2009). Phosphoinositide 3-kinase p1 10 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoan-tibody responses. J. Immunol. 183, 5673-5684.
24. Finlay, D., and Cantrell, D. (2010). Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann. N.Y. Acad. Sci. 1183, 149-157.
25. Fruman, D. A., and Rommel, C. (2011). PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic. Cancer Discov. 1,562-572.
26. Furman, R. R., Byrd, J. C., Brown, J. R., Coutre, S. E., Benson, D. M. Jr., Wagner-Johnston, N. D., Flinn, I. W., Kahl, B. S., Spurgeon, S. E., Lannutti, B., Giese, N. A., Webb, H. K., Ulrich, R. G., Peterman, S., Holes, L. M., and Yu, A. S. (2010). CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110{delta}, demonstrates clinical activity and pharmaco-dynamic effects in patients with relapsed or refractory chronic lymphocytic leukemia. ASH Ann. Meeting Abstr. 116,55.
27. Garcon, F., Patton, D. T., Emery, J. L., Hirsch, E., Rottapel, R., Sasaki, T., and Okkenhaug, K. (2008). CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111, 1464-1471.
28. Gogishvili, T., Elias, F., Emery, J. L., Mcpherson, K., Okkenhaug, K., Hunig, T., and Dennehy, K. M. (2008). Proliferative signals mediated by CD28 superagonists require the exchange factor Vav1 but not phosphoinositide 3-kinase in primary peripheral T cells. Eur. J. Immunol. 38, 2528-2533.
29. Gottschalk, R. A., Corse, E., and Allison, J. P. (2010). TCR lig-and density and affinity determine peripheral induction of Foxp3 in vivo.J. Exp. Med. 207, 1701-1711.
30. Grohmann, U., Orabona, C., Fallarino, E, Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., and Puccetti, P. (2002). CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101.
31. Guo, W., Schubbert, S., Chen, J. Y., Valamehr, B., Mosessian, S., Shi, H., Dang, N. H., Garcia, C., Theodoro, M. F., Varella-Garcia, M., and Wu, H. (2011). Suppression of leukemia development caused by PTEN loss. Proc. Natl. Acad. Sci. U.S.A. 108, 1409-1414.
32. Harada, Y., Elly, C., Ying, G., Paik, J. H., Depinho, R. A., and Liu, Y C. (2010). Transcription factors Foxo3a and Foxo1 couple the E3 lig-ase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 207, 1381-1391.
33. Haxhinasto, S., Mathis, D., and Benoist, C. (2008). The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565-574.
34. Haylock-Jacobs, S., Comerford, I., Bunting, M., Kara, E., Townley, S., Klingler-Hoffmann, M., Vanhaesebroeck, B., Puri, K. D., and Mccoll, S. R. (2011). PI3Kdelta drives the pathogene-sis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J. Autoimmun. 36, 278-287.
35. Hsieh, C.-S., Lee, H.-M., and Lio, C.-W J. (2012). Selection of regulatory T cells in the thymus. Nat. Rev. Immunol. 12, 157-167.
36. Hubert, S., Rissiek, B., Klages, K., Huehn, J., Sparwasser, T., Haag, E, Koch-Nolte, F., Boyer, O., Seman, M., and Adriouch, S. (2010). Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J. Exp. Med. 207, 2561-2568.
37. Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G., Wilkinson, N., Banerjee, A., Proietto, A., Gugasyan, R., Wu, L., Mcnally, A., Steptoe, R. J., Thomas, R., Shannon, M. F., and Gerondakis, S. (2009). c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 206,3001-3014.
38. Jarmin, S. J., David, R., Ma, L., Chai, J. G., Dewchand, H., Takesono, A., Ridley, A. J., Okkenhaug, K., and Marelli-Berg, E M. (2008). T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice. J. Clin. Invest. 118, 1154-1164.
39. Josefowicz, S. Z., Lu, L. F., and Rudensky, A. Y. (2012a). Regulatory T Cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564.
40. Josefowicz, S. Z., Niec, R. E., Kim, H. Y., Treuting, P., Chinen, T., Zheng, Y., Umetsu, D. T., and Rudensky, A Y (2012b). Extrathymically gen erated regulatory T cells control mucosal TH2 inflammation. Nature 482,395-399.
41. Kashiwada, M., Cattoretti, G., McKeag, L., Rouse, T., Showalter, B. M., Al-Alem, U., Niki, M., Pandolfi, P. P., Field, E. H., and Rothman, P. B (2006). Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development. J. Immunol. 176, 3958-3965.
42. Kerdiles, Y M., Beisner, D. R., Tinoco, R., Dejean, A. S., Castrillon, D. H., Depinho, R. A., and Hedrick, S. M. (2009). Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and inter-leukin 7 receptor. Nat. Immunol. 10, 176-184.
43. Kerdiles, Y M., Stone, E. L., Beisner, D. L., McGargill, M. A., Ch'en, I. L., Stockmann, C., Katayama, C. D., and Hedrick, S. M. (2010). Foxo transcription factors control regulatory T cell development and function. Immunity 33, 890-904.
44. Kim, J. M., Rasmussen, J. P., and Rudensky, A. Y (2007). Regulatory T cells prevent catastrophic autoim-munity throughout the lifespan of mice. Nat. Immunol. 8, 191-197.
45. Komatsu, N., Mariotti-Ferrandiz, M. E., Wang, Y., Malissen, B., Waldmann, H., and Hori, S. (2009). Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. U.S.A. 106, 1903-1908.
46. Lio, C. W., and Hsieh, C. S. (2008). A two-step process for thymic regulatory T cell development. Immunity 28, 100-111.
47. Liu, D., Zhang, T., Marshall, A. J., Okkenhaug, K., Vanhaesebroeck, B., and Uzonna, J. E. (2009). The p 1 10delta isoform of phosphatidyli-nositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 183, 1921-1933.
48. Liu, X., Karnell, J. L., Yin, B., Zhang, R., Zhang, J., Li, P., Choi, Y., Maltzman, J. S., Pear, W. S., Bassing, C. H., and Turka, L. A. (2010). Distinct roles for PTEN in prevention of T cell lymphoma and autoimmu-nity in mice. J. Clin. Invest. 120, 2497-2507.
49. Locke, N. R., Patterson, S. J., Hamilton, M. J., Sly, L. M., Krystal, G., and Levings, M. K. (2009). SHIP regulates the reciprocal development of T regulatory and Th17 cells. J. Immunol. 183, 975-983.
50. Macintyre, A. N., Finlay, D., Preston, G., Sinclair, L. V., Waugh, C. M., Tamas, P., Feijoo, C., Okkenhaug, K., and Cantrell, D. A. (2011). Protein kinase B controls transcrip-tional programs that direct cyto-toxic T cell fate but is dispensable for T cell metabolism. Immunity 34, 224-236.
51. Marshall, N. A., Galvin, K. C., Corcoran, A.-M. B., Boon, L., Higgs, R., and Mills, K. H. G. (2012). Immunotherapy with PI3K inhibitor and toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors. Cancer Res. 72, 581-591.
52. Martin, A. L., Schwartz, M. D., Jameson, S. C., and Shimizu, Y. (2008). Selective regulation of CD8 effector T cell migration by the p 110 gamma isoform of phosphatidyli-nositol 3-kinase. J. Immunol. 180, 2081-2088.
53. Mcmanus, E. J., Collins, B. J., Ashby, P. R., Prescott, A. R., Murray-Tait, V., Armit, L. J., Arthur, J. S., and Alessi, D. R. (2004). The in vivo role of PtdIns(3, 4, 5)P3 binding to PDK1 PH domain defined by knockin mutation. EMBO J. 23, 2071-2082.
54. Merkenschlager, M., and Von Boehmer, H. (2010). PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J. Exp. Med. 207, 1347-1350.
55. Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., Maciver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., and Rathmell, J. C. (2011). Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299-3303.
56. Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H. J., Waldmann, H., Huehn, J., and Hori, S. (2012). Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262-275.
57. Nashed, B. F., Zhang, T., Al-Alwan, M., Srinivasan, G., Halayko, A. J., Okkenhaug, K., Vanhaesebroeck, B., Hayglass, K. T., and Marshall, A. J. (2007). Role of the phosphoinosi-tide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur. J. Immunol. 37, 416-424.
58. Norman, P. (2011). Selective PI3Kdelta inhibitors, a review of the patent literature. Expert Opin. Ther. Pat. 21, 1773-1790.
59. Oak, J. S., Deane, J. A., Kharas, M. G., Luo, J., Lane, T. E., Cantley, L. C., and Fruman, D. A. (2006). Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. U.S.A. 103, 16882-16887.
60. Ohkura, N., Hamaguchi, M., and Sakaguchi, S. (2011). FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents. Trends Pharmacol. Sci. 32, 158-166.
61. Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S. E., Salpekar, A., Waterfield, M. D., Smith, A. J. H., and Vanhaesebroeck, B. (2002). Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297, 1031-1034.
62. Okkenhaug, K., and Fruman, D. A. (2010). PI3Ks in lymphocyte signaling and development. Curr. Top. Microbiol. Immunol. 346, 57-85.
63. Okkenhaug, K., Patton, D. T., Bilancio, A., Garcon, F., Rowan, W. C., and Vanhaesebroeck, B. (2006). The p110delta isoform of phospho-inositide 3-kinase controls clonal expansion and differentiation of Th cells.J. Immunol. 177, 5122-5128.
64. Ouyang, W., Beckett, O., Ma, Q., Paik, J. H., Depinho, R. A., and Li, M. O. (2010). Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11,618-627.
65. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., and Lenardo, M. J. (2007). CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353-1362.
66. Pandiyan, P., Zheng, L., and Lenardo, M. (2011). Suppressive and immunoprotective functions of Tregs. Front. Immunol. 2:60. doi: 10.3389/fimmu.2011.00060
67. Park, S. G., Mathur, R., Long, M., Hosh, N., Hao, L., Hayden, M. S., and Ghosh, S. (2010). T regulatory cells maintain intestinal homeosta-sis by suppressing gammadelta T cells. Immunity 33, 791-803.
68. Patterson, S. J., Han, J. M., Garcia, R., Assi, K., Gao, T., O'neill, A., Newton, A. C., and Levings, M. K. (2011). Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J. Immunol. 186, 5533-5537.
69. Patton, D. T., Garden, O. A., Pearce, W. P., Clough, L. E., Monk, C. R., Leung, E., Rowan, W C, Sancho, S., Walker, L. S. K., Vanhaesebroeck, B., and Okkenhaug, K. (2006). Cutting edge: the phosphoinositide 3-kinase p110[delta] is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177, 6598-6602.
70. Patton, D. T., Wilson, M. D., Rowan, W. C., Soond, D. R., and Okkenhaug, K. (2011). The PI3K p110delta regulates expression of CD38 on regulatory T cells. PLoS ONE 6:e17359. doi: 10.1371/journal.pone.0017359
71. Pierau, M., Engelmann, S., Reinhold, D., Lapp, T., Schraven, B., and Bommhardt, U. H. (2009). Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation. J. Immunol. 183, 6124-6134.
72. Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., Hou, T. Z., Futter, C. E., Anderson, G., Walker, L. S., and Sansom, D. M. (2011). Trans-endocytosis of CD80 and CD86, a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603.
73. Read, S., Malmstrom, V., and Powrie, F. (2000). Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302.
74. Rolf, J., Bell, S. E., Kovesdi, D., Janas, M. L., Soond, D. R., Webb, L. M., Santinelli, S., Saunders, T., Hebeis, B., Killeen, N., Okkenhaug, K., and Turner, M. (2010). Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J. Immunol. 185, 4042-4052.
75. Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., and Rudensky, A. Y. (2010). Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671.
76. Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R. Jr., Muller, W., and Rudensky, A. Y. (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558.
77. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L., and Sabatini, D. M. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168.
78. Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight, Z. A., Cobb, B. S., Cantrell, D., O'connor, E., Shokat, K. M., Fisher, A. G., and Merkenschlager, M. (2008). T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 105, 7797-7802.
79. Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., and Chi, H. (2011). HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376.
80. Sinclair, L. V., Finlay, D., Feijoo, C., Cornish, G. H., Gray, A., Ager, A., Okkenhaug, K., Hagenbeek, T. J., Spits, H., and Cantrell, D. A. (2008). Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 9, 513-521.
81. So, L., and Fruman, D. A. (2012). PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochem. J. 442, 465-481.
82. Soond, D. R., Bjorgo, E., Moltu, K., Dale, V. Q., Patton, D. T., Torgersen, K. M., Galleway, F., Twomey, B., Clark, J., Gaston, J. S., Tasken, K., Bunyard, P., and Okkenhaug, K. (2010). PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood 115, 2203-2213.
83. Soond, D. R., Garcon, F., Patton, D. T., Rolf, J., Turner, M., Scudamore, C., Garden, O. A., and Okkenhaug, K. (2012). Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmu-nity or lymphoma. J. Immunol. 188, 5935-5943.
84. Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M., Tsubata, T., Ohashi, P. S., Koyasu, S., Penninger, J. M., Nakano, T., and Mak, T. W. (2001). T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523-534.
85. Thomas, M. S., Mitchell, J. S., Denucci, C. C., Martin, A. L., and Shimizu, Y. (2008). The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites. J. Leukoc. Biol. 84, 814-823.
86. Tsuji, M., Komatsu, N., Kawamoto, S., Suzuki, K., Kanagawa, O., Honjo, T., Hori, S., and Fagarasan, S. (2009). Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 323, 1488-1492.
87. Uno, J. K., Rao, K. N., Matsuoka, K., Sheikh, S. Z., Kobayashi, T., Li, F., Steinbach, E. C., Sepulveda, A. R., Vanhaesebroeck, B., Sartor, R. B., and Plevy, S. E. (2010). Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110delta. Gastroenterology 139,1642-1653,e1641-e1646
88. Visekruna, A., Huber, M., Hellhund, A., Bothur, E., Reinhard, K., Bollig, N., Schmidt, N., Joeris, T., Lohoff, M., and Steinhoff, U. (2010). c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur. J. Immunol. 40, 671-676.
89. Walsh, P. T., Buckler, J. L., Zhang, J., Gelman, A. E., Dalton, N. M., Taylor, D. K., Bensinger, S. J., Hancock, W W., and Turka, L. A. (2006). PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J. Clin. Invest. 116,2521-2531.
90. Wan, Y Y, and Flavell, R. A. (2007). Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770.
91. Waugh, C., Sinclair, L., Finlay, D., Bayascas, J. R., and Cantrell, D. (2009). Phosphoinositide (3,4, 5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol. Cell. Biol. 29, 5952-5962.
92. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., Bricarelli, F. D., Byrne, G., Mceuen, M., Proll, S., Appleby, M., and Brunkow, M. E. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20.
93. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., and Sakaguchi, S. (2008). CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275.
94. Yamaguchi, T., Wing, J. B., and Sakaguchi, S. (2011). Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Semin. Immunol. 23, 424-430.
95. Yokosuka, T., Kobayashi, W., Takamatsu, M., Sakata-Sogawa, K., Zeng, H., Hashimoto-Tane, A., Yagita, H., Tokunaga, M., and Saito, T. (2010). Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 33, 326-339.
96. Yurchenko, E., Shio, M. T., Huang, T. C., Da Silva Martins, M., Szyf, M., Levings, M. K., Olivier, M., and Piccirillo, C. A. (2012). Inflammation-driven repro-gramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS ONE 7:e35572. doi: 10.1371/journal.pone.0035572
97. Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X. P., Forbush, K., and Rudensky, A. Y (2010). Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812.
98. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., and Bluestone, J. A. (2009). Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.
99. Zuber, J., Hermine, O., Chatenoud, L., and Legendre, C. (2011). Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality? Curr. Opin. Organ Transplant. 16, 606-613.